ARTICLE SUMMARY:
The recent annual meeting of the North American Neuromodulation Society presented the latest research on neuromodulation. In this meeting wrap-up, we focus on spinal cord stimulation for pain, which dominated the meeting in terms of attendees and presentations, and where, after 50 years of a “one therapy fits all” paradigm, innovation is accelerating with a new focus on Level 1 clinical trials, understanding mechanisms of action, and personalizing SCS therapy.
There was a lot to unpack at the recent annual meeting of the North American Neuromodulation Society (NANS), the world’s largest gathering dedicated to advances in both the science and practice of neuromodulation.
